SCHEMBL16626699

SCHEMBL16626699

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(OC)nc3C)ccc12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.35
IDE P14735 1/20 0.35
FBP1 P09467 1/20 0.35
CYP17A1 P05093 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
P2RX7 Q99572 4/20 0.34
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
TSHR P16473 1/20 0.33
PIK3CG P48736 1/20 0.33
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
CYP19A1 P11511 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618944 0.99 HTR6 (0.35) HTR6IDEFBP1CYP17A1MTNR1A
SCHEMBL16626728 0.91 FBP1 (0.37) HTR6IDEFBP1MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL16619198 0.91 FBP1 (0.37) HTR6IDEFBP1MTNR1AMTNR1B
SCHEMBL17971539 0.90 IDE (0.37) HTR6IDEFBP1TSHRCYP19A1
Hydrochloric Acid SCHEMBL16618653 0.89 IDE (0.36) HTR6IDEFBP1TSHRCYP19A1
SCHEMBL16626478 0.89 IDE (0.36) HTR6IDEFBP1TSHRCYP19A1
SCHEMBL17971542 0.89 IDE (0.36) HTR6IDEFBP1CYP17A1CYP19A1
Hydrochloric Acid SCHEMBL16618613 0.88 IDE (0.36) HTR6IDEFBP1TSHRCYP19A1
Hydrochloric Acid SCHEMBL16619506 0.88 IDE (0.36) HTR6IDEFBP1CYP17A1CYP19A1
SCHEMBL17971537 0.87 IDE (0.38) HTR6IDECYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885IDE 2586/4885FBP1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.